Best in Biotech 6 Apr 2023
Cancer vaccines: 10 biotech companies that have changed the game
A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered…
Scancell
- Latest Posts
News and Trends 14 Feb 2023
Scancell looking to partner after positive COVID vaccine data
Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease, has announced preliminary immunogenicity data…
News and Trends 7 Nov 2022
Scancell in-licenses Vaccitech’s SNAPvax tech for cancer study
Scancell Holdings plc, a developer of immunotherapies, today (November 7) announced it has in-licensed the SNAPvax technology from Vaccitech plc,…
News and Trends 31 Oct 2022
First patient enrolled and dosed on expansion phase of cancer treatment trial
The first patient in an expansion phase of a trial looking at cancer drug Modi-1 has been enrolled and dosed.…
ADVERTISEMENT
News and Trends 26 Oct 2022
Scancell signs agreement with Genmab
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious disease, has signed a licensing…
News and Trends 16 Feb 2021
Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze
The major research funder CRUK and two of the biotech companies it works with have decided to cut development ties…
News and Trends 9 Jan 2018
Scancell and BioNTech Will Combine Their Expertise to Fight Cancer
Scancell has brought in BioNTech to develop T-cell receptors against specific target proteins in cancer cells, opening the door to…
